54.73
전일 마감가:
$55.80
열려 있는:
$56.08
하루 거래량:
1.77M
Relative Volume:
0.72
시가총액:
$8.33B
수익:
$3.46B
순이익/손실:
$-9.40M
주가수익비율:
-227.66
EPS:
-0.2404
순현금흐름:
$51.30M
1주 성능:
-0.35%
1개월 성능:
+27.64%
6개월 성능:
+23.24%
1년 성능:
+45.48%
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
54.73 | 8.62B | 3.46B | -9.40M | 51.30M | -0.2404 |
|
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 개시 | Goldman | Sell |
| 2025-11-20 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-10-15 | 개시 | Barclays | Overweight |
| 2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2022-10-21 | 개시 | UBS | Buy |
| 2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 개시 | Goldman | Sell |
| 2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-06-24 | 재확인 | Needham | Strong Buy |
| 2019-06-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
| 2019-05-06 | 재확인 | Needham | Strong Buy |
| 2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
| 2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 재확인 | BTIG Research | Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker Corp (BRKR) Stock Up 4.4% and Still Undervalued -- GF Score: 85/100 - GuruFocus
Broker Technologies (BRKR) files Form 144 to sell 2,000 shares (06/15/2026) - Stock Titan
Bruker Q2 2025 Earnings Preview - MSN
Bruker Corporation (NASDAQ: BRKR) files S-3 shelf for equity, debt and resale offerings - Stock Titan
Bruker Corp (BRKR) Stock Down 4.0% -- Now Undervalued? GF Score: 85/100 - GuruFocus
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders - Yahoo Finance
BRKR News | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker advances 4D proteomics, functional proteoform analysis and hybrid metabolomics at ASMS 2026 - Select Science
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65 - 富途牛牛
Is Bruker Corporation (BRKR) A Good Stock To Buy Now? - Yahoo Finance
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam - Yahoo Finance
BRKR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Legal & General Group Plc Sells 43,599 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Bruker (BRKR) Showcases Innovations in Microbiology at ASM Micro - GuruFocus
Bruker (BRKR) Advances Microbial Diagnostics at ASM Microbe 2026 - GuruFocus
Bruker showcases expanded microbiology diagnostics portfolio By Investing.com - Investing.com Canada
Bruker showcases expanded microbiology diagnostics portfolio - Investing.com
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - Caledonian Record
Bruker Corporation $BRKR Shares Bought by BNP Paribas Financial Markets - MarketBeat
Is Bruker Corp (BRKR) Overvalued After 9.4% Rally? GF Value Says - GuruFocus
Bruker shares jump as new ASMS launches spotlight proteomics, energy, and semiconductor demand - Quiver Quantitative
Bruker Corp. Hits New 52-Week High at USD 58.98 - MarketsMojo
Bruker Corp. Hits Day High with 8.27% Surge in Strong Intraday Performance - Markets Mojo
Bruker Corporation Releases timsMRMS Platform for Analysis of Complex Chemical Mixtures - geneonline.com
Bruker launches timsMRMS system for energy research By Investing.com - Investing.com India
Bruker launches timsMRMS system for energy research - Investing.com
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry - Yahoo Finance
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $65 - 富途牛牛
Bruker’s new tool targets longer-lasting lithium batteries, cleaner fuels - Stock Titan
Wolfe Research Initiates Bruker Corp(BRKR.US) With Hold Rating - Moomoo
Bruker (BRKR) Faces Downgrade from Wolfe Research - GuruFocus
Wolfe Research initiates Bruker stock coverage with Peerperform - Investing.com UK
Wolfe Research initiates Bruker stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Bruker (BRKR) Launches Innovative timsMRMS System - GuruFocus
Is It Time To Consider Buying Bruker Corporation (NASDAQ:BRKR)? - Moomoo
Bruker to pay $3.9844 per share to preferred holders Mar. 2 - Stock Titan
Bruker launches air exposomics tools to link pollution and disease - Stock Titan
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp. Hits Day High with 11.87% Surge in Strong Performance - Markets Mojo
Bruker Corp stock (US1167941087): valuation focus as shares hover near recent highs - AD HOC NEWS
Bruker (NASDAQ: BRKR) details 2026 vote results and technical 8-K/A update - Stock Titan
Bruker stock hits 52-week high at $56.25 By Investing.com - Investing.com South Africa
Bruker Momentum Builds Across Life Sciences Tools Market - Kalkine Media
Bruker stock hits 52-week high at $56.25 - Investing.com
Q1 Earnings Highs And Lows: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Bruker Shares Surge Following Strong (NASDAQ:BRKR) And Analyst Revisions - Kalkine Media
Bruker (NASDAQ:BRKR) Shares Up 9.2%Time to Buy? - MarketBeat
Bruker Corp (BRKR) Stock Up 3.6% and Still Undervalued -- GF Sco - GuruFocus
Bruker (BRKR) Unveils Advanced BioSpec 18T MRI System in Lisbon - GuruFocus
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bruker Corp 주식 (BRKR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jun 15 '26 |
Sale |
54.76 |
2,000 |
109,520 |
128,443 |
자본화:
|
볼륨(24시간):